Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Treace Medical Concepts, Inc. - Common Stock (NQ:TMCI)

6.720 -0.030 (-0.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 414,968
Open 6.700
Bid (Size) 5.000 (1)
Ask (Size) 7.990 (1)
Prev. Close 6.750
Today's Range 6.660 - 6.870
52wk Range 4.540 - 10.79
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Alert: Grabar Law Office is Investigating Claims on Behalf Long-Term Shareholders of Methode Electronics, Inc. (NYSE: MEI); Treace Medical Concepts, Inc. (NASDAQ: TMCI); Virtu Financial Inc. (NASDAQ: VIRT); and West Pharmaceutical Services, Inc.
From Grabar Law Office
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
From Pomerantz LLP
Via GlobeNewswire

Performance

YTD
-14.6%
-14.6%
1 Month
+3.1%
+3.1%
3 Month
-33.3%
-33.3%
6 Month
-11.7%
-11.7%
1 Year
+19.4%
+19.4%

More News

Read More
TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Treace Medical Concepts, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Earnings Scheduled For May 8, 2025
Via Benzinga
Alert: Grabar Law Office is Investigating Claims on Behalf Long-Term Shareholders of Applovin Corporation (NASDAQ: APP); Maison Solutions, Inc. (NASDAQ: MSS); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VIRT)
From Grabar Law Office
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
From Pomerantz LLP
Via GlobeNewswire
SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)
From Bernstein Liebhard LLP
Via GlobeNewswire
Treace Medical Concepts Reports First Quarter 2025 Financial Results
From Treace Medical Concepts, Inc.
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
From Pomerantz LLP
Via GlobeNewswire
TMCI Investors are Urged to Contact Robbins LLP for Information About the Treace Medical Concepts, Inc. Class Action Lawsuit
Via NewMediaWire
TMCI Investors are Urged to Contact Robbins LLP for Information About the Treace Medical Concepts, Inc. Class Action Lawsuit
Via TheNewswire.com
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI
From The Rosen Law Firm PA
Via GlobeNewswire
Treace Medical Concepts, Inc. Stock News: Shareholder Rights Law firm Robbins LLP Reminds TMCI Stockholders of the Securities Fraud Class Action
Via NewMediaWire
Topics Fraud
Exposures Legal
Treace Medical Concepts, Inc. Stock News: Shareholder Rights Law firm Robbins LLP Reminds TMCI Stockholders of the Securities Fraud Class Action
Via TheNewswire.com
Topics Fraud
Exposures Legal
Long-Term Treace Medical Concepts, Inc. (NASDAQ: TMCI) Shareholder Notice: Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
Robbins LLP Reminds TMCI Investors of the Opportunity to Lead the Class Action Against Treace Medical Concepts, Inc.
Via NewMediaWire
Robbins LLP Reminds TMCI Investors of the Opportunity to Lead the Class Action Against Treace Medical Concepts, Inc.
Via TheNewswire.com
TMCI Investors Have the Opportunity to Lead the Treace Medical Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
From Faruqi & Faruqi LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
From Pomerantz LLP
Via GlobeNewswire
TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Treace Medical Concepts, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical
From Faruqi & Faruqi LLP
Via GlobeNewswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI
From The Rosen Law Firm PA
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI
From Pomerantz LLP
Via GlobeNewswire
Treace to Report First Quarter 2025 Financial Results on May 8, 2025
From Treace Medical Concepts, Inc.
Via GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical
From Faruqi & Faruqi LLP
Via GlobeNewswire

Frequently Asked Questions

Is Treace Medical Concepts, Inc. - Common Stock publicly traded?
Yes, Treace Medical Concepts, Inc. - Common Stock is publicly traded.
What exchange does Treace Medical Concepts, Inc. - Common Stock trade on?
Treace Medical Concepts, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Treace Medical Concepts, Inc. - Common Stock?
The ticker symbol for Treace Medical Concepts, Inc. - Common Stock is TMCI on the Nasdaq Stock Market
What is the current price of Treace Medical Concepts, Inc. - Common Stock?
The current price of Treace Medical Concepts, Inc. - Common Stock is 6.720
When was Treace Medical Concepts, Inc. - Common Stock last traded?
The last trade of Treace Medical Concepts, Inc. - Common Stock was at 05/16/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.